Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin-Ezetimibe vs Statin Monotherapy in Ischemic Stroke
NCT07307989Phase 2Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Aug 2025
- Primary completion
- Jul 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ezetimibe in ischemic stroke, hypercholesterolemia, sponsored by Chang Gung Memorial Hospital. Started Aug 2025; status: recruiting.
02
Drugs
ezetimibe
03
Conditions
ischemic strokehypercholesterolemia
Beyond the preview
Go deeper on NCT07307989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07307989.